Respiratory Therapeutics Group Company Profile

06:50 EDT 20th September 2019 | BioPortfolio

RTG is a global manufacturer of Respiratory Devices, with an extensive brand portfolio of respiratory disposable devices, products and service solutions designed by Respiratory Therapists for a diverse range of therapies. RTG Products are distributed in Acute, Sub Acute, Skilled Nursing, Home and Hospice Settings, through our increasing network of distribution partners.

News Articles [2006 Associated News Articles listed on BioPortfolio]

Zambon Acquires Breath Therapeutics for Up-to-€500M, Adding to Respiratory Pipeline

Italian pharma Zambon said today it has acquired Breath Therapeutics and its subsidiaries for up to €500 million (about $559 million), in a deal that adds a Phase III program to the buyer’s severe...

.@MariaBelvisi4, is an internationally recognised expert in the respiratory field. She leads early Respiratory R&D and retains her role in academia as head of the Respiratory Pharmacology group at @imperialcollege.

. @MariaBelvisi4, is an internationally recognised expert in the respiratory field. She leads early Respiratory R&D and retains her role in academia as head of the Respiratory Pharmacology group a...

Circassia Pharmaceuticals says partner AIT Therapeutics successfully completes FDA pre-submission meeting

The group said AIT anticipates submitting a Premarket Approval application for AirNOvent in the second quarter of 2019 for use in the treatment of hypoxic respiratory failure associated with persisten...

Zambon’s acquisition creates position to ‘achieve advances’ for respiratory diseases

Zambon acquires Breath Therapeutics for â140m to accelerate the commercialization of treatments for severe respiratory diseases.

Respiratory Drug Delivery 2019

5 - 6 December 2019, London, UK. SMi are pleased to announce the launch of the Respiratory Drug Delivery conference as part of the newly branded Asthma and COPD series. With the rising prevalence of r...

Breath Therapeutics scooped up by Zambon for up to €500mm

Zambon Co. SPA is acquiring respiratory-focused start-up Breath Therapeutics Holdings BV for €140mm ($156mm) up front and up to €360mm ($401mm) in earn-outs tied to the achievement of regulatory a...

Trajectory of Physical Function Recovery May Help Inform Prognosis for Survivors of Acute Respiratory Failure

There are several distinct trajectories of recovery after acute respiratory failure. The group with the highest physical function consisted primarily of younger women who experienced less continuous s...

Exclusive: Breath Therapeutics Launches Phase III Trial to Bring Relief to BOS Patients

In five years it is estimated that about 25,000 people in the United States will develop bronchiolitis obliterans syndrome (BOS), which results in respiratory failure and death. But a late-stage treat...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]


Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]


Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [3437 Associated PubMed Articles listed on BioPortfolio]

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.

The International Society for Influenza and other Respiratory Virus Diseases held its 6th Antiviral Group (isirv-AVG) conference in Rockville, Maryland, November 13-15, 2018. The three-day program was...

Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness.

Effective therapeutics for respiratory viruses are needed. Early data suggest Nitazoxanide (NTZ) may be beneficial for treating acute respiratory viral illness.

Effects of SI and PCV on respiratory mechanics, early central drive and hemodynamics in patients with ARDS.

Effects of sustained inflation (SI) and pressure- controlled ventilation (PCV) on respiratory mechanics, early central drive, and hemodynamics in patients with acute respiratory distress syndrome (ARD...


The aim of the present study is to investigate the effects of inspiratory muscle training (IMT) on pulmonary function and respiratory muscle strength of both healthy smokers and nonsmokers. Forty-two ...

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.

Middle East respiratory syndrome (MERS) coronavirus causes a highly fatal lower-respiratory tract infection. There are as yet no licensed MERS vaccines or therapeutics. This study (WRAIR-2274) assesse...

Clinical Trials [7794 Associated Clinical Trials listed on BioPortfolio]

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Effectiveness of Respiratory Physiotherapy in Children With Neuromuscular Disease

The main objective of this study is to determine whether the Respiratory Physiotherapy allows improvement or maintenance of respiratory function in children with Neuromuscular Diseases, ag...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome

The best mode of delivery room stabilization for premature infants at high risk for respiratory distress syndrome is unknown. The protocol evaluates the impact of three distinct methods of...

Companies [3357 Associated Companies listed on BioPortfolio]

Respiratory Therapeutics Group

RTG is a global manufacturer of Respiratory Devices, with an extensive brand portfolio of respiratory disposable devices, products and service solutions designed by Respira...

Therabron Therapeutics, Inc.

Therabron Therapeutics, Inc. is a clinical-stage biotechnology company, founded in 2007 and located in Rockville, MD. Therabron is focused on the advancement of respiratory therap...

Pearl Therapeutics Inc.

Pearl Therapeutics is developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma. Leveraging its pro...

Respira Therapeutics

Respira Therapeutics is an early-stage product development company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company rea...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Respiratory Therapeutics Group" on BioPortfolio

We have published hundreds of Respiratory Therapeutics Group news stories on BioPortfolio along with dozens of Respiratory Therapeutics Group Clinical Trials and PubMed Articles about Respiratory Therapeutics Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Respiratory Therapeutics Group Companies in our database. You can also find out about relevant Respiratory Therapeutics Group Drugs and Medications on this site too.

Quick Search

Relevant Topic

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Corporate Database Quicklinks

Searches Linking to this Company Record